Shares of Sotera Health Company (SHC) surged 5.06% during intraday trading on Thursday, propelled by the company's second-quarter financial results that exceeded analyst expectations and an improved full-year forecast.

The sterilization solutions provider reported adjusted earnings per share of $0.26 for the quarter, surpassing the consensus estimate of $0.24. Quarterly revenue climbed 9.2% year-over-year to $321.38 million, also beating the analyst projection of $309.39 million. The strong performance was driven by favorable pricing, improved volume and mix across its Sterigenics and Nordion segments, and the timing of Cobalt-60 harvests.

In addition to the quarterly beat, Sotera Health raised its full-year 2026 guidance. The company now expects adjusted EPS in the range of $0.95 to $1.01, up from the prior low end of $0.93, and revenue between $1.236 billion and $1.254 billion, versus the previous range of $1.23 billion to $1.25 billion. The raised outlook reinforced investor confidence and contributed to the stock's sharp upward move.